Literature DB >> 33528938

Inhaled corticosteroids may have a protective effect against coronavirus infection.

Alicia Armentia1, Sara Fernández Cortés2, Angela Moro Simón2, Blanca Martín-Armentia2, Sara Martín-Armentia3, Daniel Ramos Pollo4, Juan Claudio Navarro Cañadas4, Javier Visa Caño4, Álvaro Sanz Rubiales5, Joaquín Rodriguez Fra5, Sara García Vaquero6, Marta Cano Pazos6, Jesús Galán de la Calle6, Edgardo Raul Lowell6, Cristina Crespo Soto7, Carmen Sánchez Toledano8, Aurora Sacristán Salgado9.   

Abstract

BACKGROUND: Spain has been severely affected by the COVID-19 epidemic, with 195,944 persons infected and 20,453 deaths at the time of writing. Older people with respiratory or cardiac conditions are most at risk.
OBJECTIVE: The aim was to compare respiratory symptoms in nursing home residents and patients with uncontrolled asthma, who are considered vulnerable to COVID-19.
METHODS: We studied 134 nursing home residents and 139 patients with uncontrolled asthma, groups vulnerable to COVID-19. Demographic characteristics, clinical manifestations, outcomes, key laboratory results, and radiological images were collected from medical records. COVID-19 infection was detected by polymerase chain reaction (PCR).
RESULTS: Thirteen (9.3%) patients with uncontrolled asthma, all receiving inhaled corticosteroids were infected by COVID-19. Eighty (60%) nursing home residents were infected; only 28, all of whom had received inhaled corticosteroids, had a good prognosis.
CONCLUSIONS: Early treatment with inhaled corticosteroids may be helpful in COVID-19 infection. Persons with an allergy might have some protective mechanisms against coronavirus.

Entities:  

Keywords:  COVID; Th2 cell immunity; allergy; asthma severe; coronavirus; coronavirus infection; corticosteroids; nursing home; telemedicine

Mesh:

Substances:

Year:  2021        PMID: 33528938     DOI: 10.15586/aei.v49i1.40

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  2 in total

1.  Leukotriene inhibitors with dexamethasone show promise in the prevention of death in COVID-19 patients with low oxygen saturations.

Authors:  Peter L Elkin; Skyler Resendez; Sarah Mullin; Bruce R Troen; Manoj J Mammen; Shirley Chang; Gillian Franklin; Wilmon McCray; Steven H Brown
Journal:  J Clin Transl Sci       Date:  2022-05-16

Review 2.  Understanding and Managing Severe Asthma in the Context of COVID-19.

Authors:  Bárbara Kong-Cardoso; Amélia Ribeiro; Rita Aguiar; Helena Pité; Mário Morais-Almeida
Journal:  Immunotargets Ther       Date:  2021-12-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.